Regulatory Focus

MDUFA V: Deficiency letters, staffing and funding emerge as issues in early negotiations

20 April 2021 | By Michael Mezher

After a delayed start, the US Food and Drug Administration (FDA) released minutes from the first two meetings held with the medical ...

Regulatory Exchange